Institute for Translational Medicine and Therapeutics

Institute for Translational Medicine and Therapeutics
Name	Institute for Translational Medicine and Therapeutics
Established	2008
Type	Research institute
Location	Philadelphia, Pennsylvania
Affiliations	University of Pennsylvania; Children's Hospital of Philadelphia
Director	(position varies)

Contents

Institute for Translational Medicine and Therapeutics is a biomedical research institute located in Philadelphia affiliated with the University of Pennsylvania and clinical partners such as Children's Hospital of Philadelphia and Penn Medicine. The institute focuses on moving discoveries from laboratories at institutions like the Perelman School of Medicine into clinical trials with partners including National Institutes of Health and Food and Drug Administration. It serves as a hub connecting investigators from entities such as Hospital of the University of Pennsylvania, Wistar Institute, and regional organizations including Thomas Jefferson University and Drexel University.

History

The institute was formed amid national initiatives like the Clinical and Translational Science Awards program and collaborations influenced by policies from the National Center for Advancing Translational Sciences and National Institute of General Medical Sciences, drawing researchers from laboratories led by figures associated with Howard Hughes Medical Institute investigators and faculty from the Perelman School of Medicine. Early partnerships included consortia with Children's Hospital of Philadelphia and collaborations with federal programs such as Biomedical Advanced Research and Development Authority and grant awards from the National Institutes of Health, linking to local research enterprises like the Wistar Institute and international contacts including Wellcome Trust investigators. Over time the institute expanded programs aligned with translational frameworks advocated by entities like the Institute of Medicine and initiatives represented at conferences such as those of the American Association for the Advancement of Science and incorporated methodologies from laboratories connected to Cold Spring Harbor Laboratory and Broad Institute collaborators.

The institute's mission aligns with strategic priorities of the University of Pennsylvania, the Perelman School of Medicine, and federal funders such as the National Institutes of Health to accelerate translation of discoveries from laboratories associated with investigators at the Wistar Institute, Children's Hospital of Philadelphia, and regional hospitals into therapies evaluated in partnerships with the Food and Drug Administration, European Medicines Agency, and philanthropic partners like the Bill & Melinda Gates Foundation. Objectives include fostering programs similar to initiatives at the Clinical and Translational Science Award hubs, building pathways used by investigators at Howard Hughes Medical Institute laboratories, and supporting career development models exemplified by awards from the National Cancer Institute and National Heart, Lung, and Blood Institute.

Research units connect investigators from departments such as Biochemistry and Biophysics, faculty affiliated with the Perelman School of Medicine, and scientists from the Wistar Institute to centers focusing on fields aligned with programs at the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of Neurological Disorders and Stroke. Thematic centers mirror efforts at institutes like the Broad Institute and encompass programs in cardiovascular science related to networks supported by the American Heart Association, oncology initiatives linked to trials coordinated with the National Cancer Institute, and infectious disease projects coordinated with collaborators such as Children's Hospital of Philadelphia and global partners like the World Health Organization. Core facilities provide services similar to those at the Perelman School of Medicine cores and include biostatistics units inspired by methods from the Johns Hopkins Bloomberg School of Public Health and preclinical platforms paralleling capabilities at the Wistar Institute.

Clinical translation activities include early-phase trials conducted with clinical partners such as Penn Medicine, Hospital of the University of Pennsylvania, and pediatric studies with Children's Hospital of Philadelphia, often under regulatory frameworks overseen by the Food and Drug Administration and ethical oversight akin to guidelines from the Office for Human Research Protections. Initiatives emphasize biomarkers validated in consortia like those organized by the National Cancer Institute and therapeutic development strategies similar to programs at the Translational Genomics Research Institute and Broad Institute. The institute supports investigator-initiated trials, collaborations with industry partners comparable to Pfizer and GlaxoSmithKline, and device testing pathways used by innovators associated with National Institutes of Health programs.

Training programs draw on instructional models from the Perelman School of Medicine, postdoctoral frameworks from the Howard Hughes Medical Institute, and clinical training formats used by Children's Hospital of Philadelphia residency programs and the Hospital of the University of Pennsylvania fellowships. Curricula include coursework similar to offerings at the Wharton School for translational entrepreneurship, grant-writing workshops that reflect standards from the National Institutes of Health, and mentorship networks connecting trainees with investigators from the Wistar Institute, the Perelman School of Medicine, and collaborators at the Broad Institute.

Strategic partnerships extend to academic institutions such as Drexel University and Thomas Jefferson University, federal agencies including the National Institutes of Health and Food and Drug Administration, philanthropic organizations like the Bill & Melinda Gates Foundation, and industry partners analogous to Johnson & Johnson and Novartis. Collaborative networks connect the institute with consortia modeled after the Clinical and Translational Science Awards hubs and with international research entities such as the Wellcome Trust and the World Health Organization, enabling multi-institutional trials and technology transfer arrangements similar to agreements seen with the Broad Institute and the Wistar Institute.

Governance structures reflect affiliations with the University of Pennsylvania and clinical partners including Children's Hospital of Philadelphia and operate under oversight mechanisms comparable to those at the Perelman School of Medicine and boards similar to university-affiliated research oversight committees. Funding sources combine federal grants from the National Institutes of Health and awards influenced by programs at the National Center for Advancing Translational Sciences, institutional support from the University of Pennsylvania, philanthropic contributions from entities like the Bill & Melinda Gates Foundation, and industry-sponsored research analogous to collaborations with Pfizer and GlaxoSmithKline.

Category:Medical research institutes in Pennsylvania